Acupuncture prevents 6-hydroxydopamine-induced neuronal death in the nigrostriatal dopaminergic system in the rat Parkinson’s disease model-Reference-Cited by-同舟云学术

Acupuncture prevents 6-hydroxydopamine-induced neuronal death in the nigrostriatal dopaminergic system in the rat Parkinson’s disease model

Published:2003-03 Issue:1 Volume:180 Page:93-98
ISSN:0014-4886
Container-title:Experimental Neurology
language:en
Short-container-title:Experimental Neurology

Author:

Park H.i-Joon,Lim Sabina,Joo Wan-Seok,Yin Chang-Shik,Lee Hyang-Sook,Lee Hye-Jung,Seo Jung-Chul,Leem Kanghyun,Son Yang-Sun,Kim Youn-Jung,Kim Chang-J.u,Kim Yong-Sik,Chung Joo-H.o

Publisher

Elsevier BV

Subject

Developmental Neuroscience,Neurology

Reference25 articles.

1. Transient increase of brain-derived neurotrophic factor mRNA expression in substantia nigra reticulata after partial lesion of the nigrostriatal dopaminergic pathway;Aliaga;Brain Res. Mol. Brain Res.,2000

2. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson’s disease;Blum;Prog. Neurobiol.,2001

3. NAIP protects the nigrostriatal dopamine pathway in an intrastriatal 6-OHDA rat model of Parkinson’s disease;Cocker;Eur. J. Neurosci.,2001

4. Acupuncture and Moxibustion;Choi,1991

5. Prospects for new restorative and neuroprotective treatments in Parkinson’s disease;Dunnet;Nature,1999

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Central Role of Hypothalamic Circuits for Acupuncture's Anti‐Parkinsonian Effects;Advanced Science;2024-08-09

2. Acupuncture influences multiple diseases by regulating gut microbiota;Frontiers in Cellular and Infection Microbiology;2024-07-08

3. Proteomics and its application in the research of acupuncture: An updated review;Heliyon;2024-06

4. Pathophysiological and therapeutic implications of neuropeptide S system in neurological disorders;Peptides;2024-05

5. Therapeutic Viewpoint on Rat Models of Locomotion Abnormalities and Neurobiological Indicators in Parkinson's Disease;CNS & Neurological Disorders - Drug Targets;2024-04